long-term investing

151 articles
The Motley FoolThe Motley Fool··David Dierking

Buy-the-Dip Strategy: Why Total Market Exposure Beats Sector Chasing

Total market ETF strategy outperforms sector chasing during volatility, providing disciplined diversification over tactical rotation.
VTIVOOmarket volatilitysector rotation
The Motley FoolThe Motley Fool··Neil Patel

Coca-Cola and Walmart: Dividend Aristocrats Offer Stability Over Growth

Coca-Cola and Walmart offer reliable income through 64 and 53 consecutive years of dividend increases, with yields of 2.72% and 0.78% respectively, though expect limited capital gains.
WMTAMZNKOWalmartdividend stocks
The Motley FoolThe Motley Fool··Reuben Gregg Brewer

Healthcare Giants BDX and MDT Offer Dividend Appeal Below $1,000 Each

Becton Dickinson and Medtronic offer attractive dividend yields of 2.4% and 2.9%, trading below $1,000 with growth potential amid sector pessimism.
MDTISRGBDXdividend stockslong-term investing
The Motley FoolThe Motley Fool··James Hires

Three Blue-Chip Dividend Stocks Offer Compounding Wealth for Long-Term Investors

Three dividend aristocrats—Pentair, Enterprise Products Partners, and T. Rowe Price Group—offer compelling income and growth opportunities with 117 combined years of consecutive dividend increases.
EPDPNRTROWdividend stockslong-term investing
The Motley FoolThe Motley Fool··Adria Cimino

Wood's AI Conviction: Ark Doubles Down on CoreWeave and Amazon Amid Tech Selloff

Cathie Wood's Ark Invest buys CoreWeave and increases Amazon positions during tech selloff, betting AI infrastructure gains from sector weakness.
NVDAAMZNCRWVARKKcloud computingAI stocks
The Motley FoolThe Motley Fool··Dan Caplinger

Lower-Cost QQQM Offers Invesco's Answer to Its Own Popular QQQ ETF

Invesco's newer QQQM ETF matches QQQ's Nasdaq 100 holdings but charges just 0.15% versus QQQ's 0.18%, potentially saving long-term investors meaningful fees.
QQQQQQMETFlong-term investing
The Motley FoolThe Motley Fool··Jason Hall

Broadcom Positioned as Top Semiconductor Play for Decade-Long Investors

Analyst identifies $AVGO as premier chip stock for long-term investors, citing AI-driven growth despite fierce competition from $NVDA and $INTC.
NVDAAMDTSMAVGOINTC+2semiconductor stockslong-term investing
The Motley FoolThe Motley Fool··Marc Guberti

Three Growth Stocks Positioned to Double: AI Boom Lifts Chipmakers and Fintech

Three growth stocks—Robinhood Markets, Micron Technology, and Iren—positioned to double on AI boom tailwinds in fintech, memory chips, and data center infrastructure.
MSFTMUHOODIRENfintechdata centers
The Motley FoolThe Motley Fool··Jason Hall

Can SoFi Stock Become a Multi-Bagger? Analyst Eyes Decade-Long Growth Path

Analyst suggests $SOFI could deliver significant returns over 10 years despite volatility and Wall Street skepticism about the fintech lender's growth trajectory.
SOFIfintechlong-term investing
The Motley FoolThe Motley Fool··Adria Cimino

Buffett's Billion-Dollar Blueprint: Why $VOO Remains His Top Pick for Ordinary Investors

Warren Buffett champions $VOO, the Vanguard S&P 500 ETF, as the ideal investment for everyday investors seeking long-term wealth. A modest $900 initial investment plus $300 monthly contributions could exceed $1 million over 35 years.
AXPBACBACpBBACpEBACpK+16ETFlong-term investing
The Motley FoolThe Motley Fool··Alex Carchidi

Wealth's Divergence: Why Billionaires Back Index Funds While Retail Chases Crypto

Billionaires favor index funds for steady wealth building while retail investors chase crypto. Index funds likely remain superior for most investors through 2035, though crypto may outperform.
SPYcryptocurrencyportfolio diversification
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Bristol Myers Squibb and Medtronic Stand Out as Defensive Healthcare Dividend Plays

BMY and MDT offer attractive dividend yields and growth potential, with BMY at 4% yield and MDT boasting 48 years of consecutive increases.
BMYCELGrMDTpharmaceuticalsdividend growth
The Motley FoolThe Motley Fool··Adria Cimino

Buffett's Legacy Lives On: Three Blue-Chip Stocks to Emulate His Winning Strategy

Buffett's retirement leaves investors with a roadmap: emulate his strategy through Apple, Coca-Cola, and American Express, exemplifying quality competitive moats and dividend growth.
AXPAAPLBRK.ABRK.BKOdividend stockslong-term investing
The Motley FoolThe Motley Fool··Leo Sun

Coca-Cola and S&P Global Emerge as Premier Dividend Kings for Income Investors

Two blue-chip dividend aristocrats offer compelling value: $KO with 64-year streak and 2.6% yield; $SPGI with 53-year streak and strong growth.
SPGIKOdividend stockslong-term investing
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Buffett's Dividend Gems: Why Coca-Cola and Visa Deserve Your $1,000

Coca-Cola and Visa offer complementary dividend strategies: one with 63 consecutive increase years, the other with 379% payout growth, both from Buffett's portfolio.
VBRK.ABRK.BKOdividend stocksdividend growth
The Motley FoolThe Motley Fool··Matt Dilallo

Three ETFs Build Lifetime Wealth: A $1,000 Blueprint for Buy-and-Hold Investors

Analysis of three ETFs—$SPY, $DGRO, and $BND—recommended as long-term core holdings for buy-and-hold investors seeking portfolio diversification and consistent returns.
SPYBNDDGROS&P 500portfolio diversification
The Motley FoolThe Motley Fool··Alex Carchidi

Bitcoin's 45% Crash Fueled by Investor Exodus, Not Market Manipulation

Bitcoin fell 45% amid manipulation allegations, but long-term holder capitulation and ETF redemptions, not concentrated trading schemes, drove the decline.
IBITBitcoin crashmarket manipulation
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Pharma Giant and Cloud Pioneer Lead Growth Stock Rally Into 2026

Analysts spotlight $LLY's obesity drug dominance and $VEEV's cloud expansion as top growth picks for first half 2026.
LLYVEEVlong-term investingGLP-1 drugs
The Motley FoolThe Motley Fool··Matt Frankel, Cfp

Two Decades Later: $10K in Vanguard S&P 500 ETF Grows to $78K

A $10,000 investment in Vanguard's S&P 500 ETF from 20 years ago would be worth nearly $78,000 today, far exceeding typical retirement savings.
VOOVSPFFlong-term investingwealth building
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Eli Lilly's Pharma Dominance: Why $LLY Attracts Long-Term Wealth Builders

$LLY dominates diabetes and weight management markets while diversifying into oncology and AI, positioning itself as a compelling long-term wealth-building investment within diversified portfolios.
NVDALLYlong-term investingdividend reinvestment